National Health Investors Inc (NYSE:NHI) has received a consensus recommendation of “Hold” from the twelve analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $74.43.

A number of analysts have issued reports on NHI shares. Zacks Investment Research raised National Health Investors from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a report on Tuesday, October 9th. Stifel Nicolaus set a $83.00 price target on National Health Investors and gave the stock a “buy” rating in a report on Tuesday, August 7th. SunTrust Banks reaffirmed a “hold” rating and set a $79.00 price target on shares of National Health Investors in a report on Wednesday, August 8th. They noted that the move was a valuation call. Cantor Fitzgerald reaffirmed a “hold” rating and set a $80.00 price target on shares of National Health Investors in a report on Thursday. Finally, Wells Fargo & Co reaffirmed a “hold” rating on shares of National Health Investors in a report on Tuesday, August 28th.

Institutional investors and hedge funds have recently bought and sold shares of the company. Truvestments Capital LLC acquired a new stake in shares of National Health Investors during the third quarter worth about $108,000. First Hawaiian Bank acquired a new stake in shares of National Health Investors during the third quarter worth about $162,000. Nissay Asset Management Corp Japan ADV acquired a new stake in shares of National Health Investors during the third quarter worth about $203,000. Zeke Capital Advisors LLC acquired a new stake in shares of National Health Investors during the second quarter worth about $201,000. Finally, MML Investors Services LLC acquired a new stake in shares of National Health Investors during the third quarter worth about $212,000. Institutional investors and hedge funds own 68.79% of the company’s stock.

NYSE NHI traded down $0.66 during trading on Monday, reaching $75.32. 199,400 shares of the company’s stock were exchanged, compared to its average volume of 207,084. The company has a market capitalization of $3.21 billion, a price-to-earnings ratio of 14.19, a price-to-earnings-growth ratio of 3.26 and a beta of 0.30. The company has a debt-to-equity ratio of 0.89, a current ratio of 14.53 and a quick ratio of 15.56. National Health Investors has a 1 year low of $62.71 and a 1 year high of $81.60.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Tuesday, November 6th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.39 by ($0.42). The business had revenue of $74.92 million for the quarter, compared to analysts’ expectations of $73.72 million. National Health Investors had a return on equity of 11.56% and a net margin of 53.15%. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. During the same period last year, the firm earned $1.37 earnings per share. As a group, equities research analysts expect that National Health Investors will post 5.5 earnings per share for the current year.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Article: Exchange-Traded Funds (ETFs)

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.